CapLaw-2018-08

  • ADC Therapeutics SA USD 200 million private placement

    On 23 October 2017, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it has raised USD 200 m through a private placement of shares. According to BioWorld.com, the placement is the fourth largest private financing round on record…

    By

    CapLaw

    Reference:
    Read more: ADC Therapeutics SA USD 200 million private placement